Ecuador vs Spain: HIV/AIDS deaths averted by antiretroviral therapy
Ecuador
3,034 deaths
in 2024
Spain
3,213 deaths
in 2024
Ecuador rank
49th
Spain rank
48th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Ecuador
- Spain
How they compare
Spain currently reports 3,213 deaths against 3,034 deaths in Ecuador, a difference of 179 deaths.
That makes Spain's figure about 1.1 times Ecuador's.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Spain ahead.
Ecuador ranks 49th and Spain ranks 48th of 157 countries.
Spain has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Ecuador | Spain | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 26.07 deaths | 1,429 deaths | 1,403 deaths | Spain |
| 2000s | 314.14 deaths | 5,789 deaths | 5,474 deaths | Spain |
| 2010s | 1,733 deaths | 4,277 deaths | 2,544 deaths | Spain |
| 2020s | 2,906 deaths | 3,345 deaths | 438.54 deaths | Spain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Ecuador or Spain?
- Spain, at 3,213 deaths against 3,034 deaths in Ecuador as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Ecuador and Spain?
- 179 deaths, with Spain ahead.
- How many years of comparable data are there for Ecuador and Spain?
- 35 years are reported by both, from 1990 to 2024.
- How do Ecuador and Spain rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Ecuador ranks 49th and Spain ranks 48th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.